Atlantic Edge Private Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$95.1K Sell
1,650
-42
-2% -$2.41K 0.02% 197
2026
Q1
$103K Buy
1,692
+42
+3% +$2.45K 0.03% 182
2025
Q4
$89K Sell
1,650
-200
-11% -$9.62K 0.02% 179
2025
Q3
$83.4K Hold
1,850
0.02% 179
2025
Q2
$85.6K Sell
1,850
-350
-16% -$17.2K 0.02% 172
2025
Q1
$134K Hold
2,200
0.04% 144
2024
Q4
$124K Sell
2,200
-100
-4% -$5.59K 0.04% 150
2024
Q3
$119K Buy
2,300
+1,000
+77% +$46.9K 0.04% 155
2024
Q2
$54K Sell
1,300
-8
-0.6% -$358 0.02% 188
2024
Q1
$70.9K Buy
1,308
+8
+0.6% +$408 0.02% 168
2023
Q4
$66.7K Buy
+1,300
New +$68.2K 0.03% 169

Other funds holding BMY

Atlantic Edge Private Wealth Management's BMY Position: Q2 2026 in Review

Atlantic Edge Private Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 2.5% in Q2 2026, selling an estimated $2.41K and leaving 1,650 shares worth $95.1K. The position accounts for 0.02% of the portfolio, ranked #197.

Atlantic Edge Private Wealth Management first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $134K in Q1 2025. 1,005 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Atlantic Edge Private Wealth Management held 1,650 shares of Bristol-Myers Squibb worth $95.1K as of Q2 2026.
  • Atlantic Edge Private Wealth Management sold 42 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.41K.
  • Bristol-Myers Squibb made up 0.02% of Atlantic Edge Private Wealth Management's portfolio in Q2 2026, its #197 holding.
  • Atlantic Edge Private Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
  • Atlantic Edge Private Wealth Management's Bristol-Myers Squibb position peaked at $134K in Q1 2025.
  • 1,005 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Atlantic Edge Private Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.